NEW YORK (GenomeWeb News) – Synthetic biology company Coda Genomics said yesterday that it has signed a collaborative agreement with biotechnology company Genencor, a division of Danish firm Danisco.
 
Under the agreement, Coda will use its proprietary approach to develop synthetic gene and protein libraries, which will be screened for use in future research programs by Genencor. Financial terms of the agreement were not disclosed.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.

People around the globe took to the streets to support science — some with signs.

Parents who learn of their increased genetic risk of disease also contend with telling their children about theirs, the New York Times writes.

In PLOS this week: loci linked to body mass index measurements, long non-coding RNA expression and urothelial carcinoma prognosis, and more.